回盛生物：12月23日召开董事会会议

Group 1 - The core viewpoint of the article highlights that Huisheng Biological (SZ 300871) held its third board meeting on December 23, 2025, to discuss the use of idle fundraising for cash management [1] - For the year 2024, Huisheng Biological's revenue composition is reported as 93.02% from veterinary raw materials and formulations, with the remaining 6.98% from other sources [1] Group 2 - As of the report, Huisheng Biological has a market capitalization of 4.2 billion yuan [2]